
Esperion Therapeutics ESPR
$ 3.38
1.66%
Quarterly report 2025-Q3
added 11-06-2025
Esperion Therapeutics Total Inventories 2011-2026 | ESPR
Annual Total Inventories Esperion Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94.5 M | 65.6 M | 35.2 M | 34.4 M | 16.1 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.5 M | 16.1 M | 49.2 M |
Quarterly Total Inventories Esperion Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109 M | 114 M | 99.3 M | 80.1 M | 84.5 M | 73.1 M | 51.4 M | 45.7 M | 39.4 M | 35.2 M | 29.5 M | - | 35.7 M | 34.4 M | 34 M | 23.7 M | 20 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 114 M | 16.1 M | 48.7 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amarin Corporation plc
AMRN
|
259 M | $ 15.08 | 2.24 % | $ 6.15 B | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.44 | -1.37 % | $ 367 M | ||
|
Amneal Pharmaceuticals
AMRX
|
612 M | $ 14.79 | 1.83 % | $ 4.57 B | ||
|
Codexis
CDXS
|
1.8 M | $ 1.26 | -1.94 % | $ 92.5 M | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.33 | 1.75 % | $ 14.6 M |